Development of cell cultures that express hepatitis B virus to high levels and accumulate cccDNA

Journal of Virological Methods

Volumn 169, Issue 1, 2010, Pages 52-60

  Lentz, Thomas B ^a,b   Loeb, Daniel D ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

CccDNA; EBNA 1; Envelope proteins; Hepatitis B virus; Intracellular amplification; Secretion

Indexed keywords

CORE PROTEIN; COVALENTLY CLOSED CIRCULAR DNA; DNA; EPSTEIN BARR VIRUS ANTIGEN 1; HYBRID PROTEIN; PROTEIN KOX1; PROTEIN TET; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA SYNTHESIS; EPSTEIN BARR VIRUS; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION;

CELL LINE; DNA, VIRAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; PLASMIDS; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; VIRUS ASSEMBLY; VIRUS REPLICATION;

HEPATITIS B VIRUS; HUMAN HERPESVIRUS 4;

EID: 77956188163     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2010.06.015     Document Type: Article

References (43)

1. Abraham T.M., Lewellyn E.B., Haines K.M., Loeb D.D. Characterization of the contribution of spliced RNAs of hepatitis B virus to DNA synthesis in transfected cultures of Huh7 and HepG2 cells. Virology 2008, 379:30-37.
2. Addison W.R., Wong W.W., Fischer K.P., Tyrrell D.L. A quantitative competitive PCR assay for the covalently closed circular form of the duck hepatitis B virus. Antiviral Res. 2000, 48:27-37.
3. Delaney W.E.t., Miller T.G., Isom H.C. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA. Antimicrob. Agents Chemother. 1999, 43:2017-2026.
4. Delmas J., Schorr O., Jamard C., Gibbs C., Trepo C., Hantz O., Zoulim F. Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro. Antimicrob. Agents Chemother. 2002, 46:425-433.
5. Deuschle U., Meyer W.K., Thiesen H.J. Tetracycline-reversible silencing of eukaryotic promoters. Mol. Cell. Biol. 1995, 15:1907-1914.
6. Dienstag J.L., Schiff E.R., Wright T.L., Perrillo R.P., Hann H.W., Goodman Z., Crowther L., Condreay L.D., Woessner M., Rubin M., Brown N.A. Lamivudine as initial treatment for chronic hepatitis B in the United States. New Engl. J. Med. 1999, 341:1256-1263.
7. Duellman S.J., Burgess R.R. Antigen-binding properties of monoclonal antibodies reactive with EBNA1 and use in immunoaffinity chromatography. PLoS One 2009, 4:e4614.
8. Fields B.N., Knipe D.M., Howley P.M. Fields Virology 2007, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia.
9. Gao W., Hu J. Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein. J. Virol. 2007, 81:6164-6174.
10. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:5547-5551.
11. Gripon P., Diot C., Theze N., Fourel I., Loreal O., Brechot C., Guguen-Guillouzo C. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J. Virol. 1988, 62:4136-4143.
12. Guo H., Jiang D., Zhou T., Cuconati A., Block T.M., Guo J.T. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation. J. Virol. 2007, 81:12472-12484.
13. Guo H., Mao R., Block T.M., Guo J.T. Production and function of the cytoplasmic deproteinized relaxed circular DNA of hepadnaviruses. J. Virol. 2010, 84:387-396.
14. Haines K.M., Loeb D.D. The sequence of the RNA primer and the DNA template influence the initiation of plus-strand DNA synthesis in hepatitis B virus. J. Mol. Biol. 2007, 370:471-480.
15. Hantz O., Parent R., Durantel D., Gripon P., Guguen-Guillouzo C., Zoulim F. Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. J. Gen. Virol. 2009, 90:127-135.
16. Hillen W., Klock G., Kaffenberger I., Wray L.V., Reznikoff W.S. Purification of the TET repressor and TET operator from the transposon Tn10 and characterization of their interaction. J. Biol. Chem. 1982, 257:6605-6613.
17. Jun-Bin S., Zhi C., Wei-Qin N., Jun F. A quantitative method to detect HBV cccDNA by chimeric primer and real-time polymerase chain reaction. J. Virol. Methods 2003, 112:45-52.
18. Kavathas P., Bach F.H., DeMars R. Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc. Natl. Acad. Sci. U.S.A. 1980, 77:4251-4255.
19. Kennedy G., Sugden B. EBNA-1, a bifunctional transcriptional activator. Mol. Cell. Biol. 2003, 23:6901-6908.
20. Kock J., Baumert T.F., Delaney W.E.t., Blum H.E., von Weizsacker F. Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes. Hepatology 2003, 38:1410-1418.
21. Kock J., Nassal M., MacNelly S., Baumert T.F., Blum H.E., von Weizsacker F. Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J. Virol. 2001, 75:5084-5089.
22. Kock J., Schlicht H.J. Analysis of the earliest steps of hepadnavirus replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity. J. Virol. 1993, 67:4867-4874.
23. Kock J., Theilmann L., Galle P., Schlicht H.J. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. Hepatology 1996, 23:405-413.
24. Ladner S.K., Otto M.J., Barker C.S., Zaifert K., Wang G.H., Guo J.T., Seeger C., King R.W. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob. Agents Chemother. 1997, 41:1715-1720.
25. Lam N., Sandberg M.L., Sugden B. High physiological levels of LMP1 result in phosphorylation of eIF2 alpha in Epstein-Barr virus-infected cells. J. Virol. 2004, 78:1657-1664.
26. Langle-Rouault F., Patzel V., Benavente A., Taillez M., Silvestre N., Bompard A., Sczakiel G., Jacobs E., Rittner K. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids. J. Virol. 1998, 72:6181-6185.
27. Lenhoff R.J., Summers J. Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus. J. Virol. 1994, 68:4565-4571.
28. Lewellyn E.B., Loeb D.D. Base pairing between cis-acting sequences contributes to template switching during plus-strand DNA synthesis in human hepatitis B virus. J. Virol. 2007, 81:6207-6215.
29. Liu N., Ji L., Maguire M.L., Loeb D.D. cis-Acting sequences that contribute to the synthesis of relaxed-circular DNA of human hepatitis B virus. J. Virol. 2004, 78:642-649.
30. Mason W.S., Halpern M.S., England J.M., Seal G., Egan J., Coates L., Aldrich C., Summers J. Experimental transmission of duck hepatitis B virus. Virology 1983, 131:375-384.
31. Miller R.H., Robinson W.S. Hepatitis B virus DNA forms in nuclear and cytoplasmic fractions of infected human liver. Virology 1984, 137:390-399.
32. Moraleda G., Saputelli J., Aldrich C.E., Averett D., Condreay L., Mason W.S. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J. Virol. 1997, 71:9392-9399.
33. Nassal M. The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J. Virol. 1992, 66:4107-4116.
34. Nguyen D.H., Ludgate L., Hu J. Hepatitis B virus-cell interactions and pathogenesis. J. Cell. Physiol. 2008, 216:289-294.
35. Summers J., O'Connell A., Millman I. Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc. Natl. Acad. Sci. U.S.A. 1975, 72:4597-4601.
36. Summers J., Smith P.M., Horwich A.L. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J. Virol. 1990, 64:2819-2824.
37. Tuttleman J.S., Pourcel C., Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 1986, 47:451-460.
38. Werle-Lapostolle B., Bowden S., Locarnini S., Wursthorn K., Petersen J., Lau G., Trepo C., Marcellin P., Goodman Z., Delaney W.E.t., Xiong S., Brosgart C.L., Chen S.S., Gibbs C.S., Zoulim F. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004, 126:1750-1758.
39. World Health Organization Introduction of hepatitis B vaccine into childhood immunization services. WHO/V&B/01. 31. 2001, http://www.who.int/vaccines-documents/.
40. Wu T.T., Coates L., Aldrich C.E., Summers J., Mason W.S. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology 1990, 175:255-261.
41. Yang W., Mason W.S., Summers J. Covalently closed circular viral DNA formed from two types of linear DNA in woodchuck hepatitis virus-infected liver. J. Virol. 1996, 70:4567-4575.
42. Yates J.L., Warren N., Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 1985, 313:812-815.
43. Zhu Y., Yamamoto T., Cullen J., Saputelli J., Aldrich C.E., Miller D.S., Litwin S., Furman P.A., Jilbert A.R., Mason W.S. Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J. Virol. 2001, 75:311-322.